TC-1698: Difference between revisions
Appearance
Content deleted Content added
Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia |
Open access status updates in citations with OAbot #oabot |
||
(17 intermediate revisions by 16 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
⚫ | |||
{{Drugbox |
|||
| |
|||
| Verifiedfields = changed |
|||
⚫ | |||
⚫ | |||
| image=TC-1698_structure.png |
|||
⚫ | |||
⚫ | |||
| image = TC-1698.svg |
|||
⚫ | |||
⚫ | |||
| ATC_prefix= |
|||
⚫ | |||
<!--Clinical data--> |
|||
⚫ | |||
| tradename = |
|||
⚫ | |||
⚫ | |||
<!--Identifiers--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 8305933 |
|||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| DrugBank= |
|||
| |
| = |
||
| molecular_weight = 202.295 |
|||
<!--Chemical data--> |
|||
| C=13 | H=18 | N=2 |
|||
| smiles = c2ncccc2C1CCC3CCN1CC3 |
| smiles = c2ncccc2C1CCC3CCN1CC3 |
||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| bioavailability= |
|||
| StdInChI = 1S/C13H18N2/c1-2-12(10-14-7-1)13-4-3-11-5-8-15(13)9-6-11/h1-2,7,10-11,13H,3-6,8-9H2 |
|||
| metabolism = |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| elimination_half-life= |
|||
| StdInChIKey = WIEWCOLOPGXZDJ-UHFFFAOYSA-N |
|||
| excretion = |
|||
| pregnancy_category = |
|||
⚫ | |||
⚫ | |||
}} |
}} |
||
'''TC-1698''' is a drug developed by [[Targacept]] which acts as a [[partial agonist]] for the [[Alpha-7 nicotinic receptor|α7]] subtype of neural [[nicotinic acetylcholine receptor]]s.<ref>{{ |
'''TC-1698''' is a drug developed by [[Targacept]] which acts as a [[partial agonist]] for the [[Alpha-7 nicotinic receptor|α7]] subtype of neural [[nicotinic acetylcholine receptor]]s.<ref>{{ |17295372}}</ref> It has [[neuroprotective]] effects in animal studies,<ref>{{ |14722323}}</ref> and has been used as a [[lead compound]] to find further potent derivatives.<ref>{{ |18363376}}</ref> |
||
==See also== |
|||
* [[Anabasine]] |
|||
== References == |
== References == |
||
{{Reflist|2}} |
{{Reflist|2}} |
||
{{Stimulants}} |
{{Stimulants}} |
||
{{Nootropics}} |
|||
{{Cholinergics}} |
|||
{{Nicotinic acetylcholine receptor modulators}} |
|||
[[Category:Nicotinic agonists]] |
[[Category:Nicotinic agonists]] |
||
[[Category:Stimulants]] |
[[Category:Stimulants]] |
||
[[Category: |
[[Category:]] |
||